Vallejo VE

Language: Spanish
References: 38
Page: 616-620
PDF size: 87.30 Kb.

Text Extraction

No abstract

REFERENCES

1. Oyer PE, Stinson EB, Jamieson SW, Hunt SA, Billingham M, Scott W, et al: Cyclosporin-A in cardiac allografting: a preliminary experience. Transplant Proc 1983; 15: 1247-52.

2. Caves PK, Stinson EB, Billingham ME: Diagnosis of human allograft rejection by serial cardiac biopsy. J Thoraci Cardiovasc Surg 1973; 66: 461-6.

3. Goswitz JJ, Braunlin E, Kubo SH, Bolman EM III, Nakhleh RE: Pathology of heart transplantation: study of autopsied and explanted allografts on emphasis on possible biopsy findings. Clin Transplant 1992; 6: 450-7.

4. Ballester M, Obrador D, Carrio I, Moya C, Auge JM, Bordes, et al: Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation 1992; 85: 61-8.

5. Haberl R, Weber M, Reichenspumer H, Kemkes BM, Osterholzer G, Anthuber M, et al: Frequency analysis of the surface electrocardiogram for recognition of acute rejection after otrhotopic cardiac transplantation in man. Circulation 1987; 76: 101-8.

6. Dubroff JM, Clarck MB, Wong CYH: Changes in left ventricular mass associated with the onset of acute rejection after cardiac transplantation. J Heart Transplant 1984; 3: 105-7.

7. Latre JM, Arizon JM, Jimenez-Heffeman A, Anguita M, Gonzalez FM, Rubio FL, et al: Noninvasive radioisotopic diagnosis of acute heart rejection. J Heart Lung Transplant 1992; 11: 453-6.

8. Valantine HA, Fowler MB, Hunt SA, Naasz C, Hatle LK, Billingham ME, et al: Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation 1987; 76: 86-92.

9. Canby RC, Evanochko WT, Barret LV, Kirklin JK, McGriffin DC, Sakai TT, et al: Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 1987; 9: 1067-74.

10. Yamamoto S, Bergsland J, Michalek S: Uptake of myocardial imaging agents by rejecting and nonrejecting cardiac transplants: A comparative clinical study of thallium-201, technetium 99m, and gallium 67. J Nucl Med 1989; 30: 1464-9.

11. Meneguetti JC, Camargo EE, Soares J Jr: Gallium-67 imaging in human heart transplantation: correlation with endomyocardial biopsy. J Heart Transplant 1987; 6: 171-6.

12. Rubin PJ, Hatman JJ, Bakke JE, Bergmann SR: Imaging of cardiac transplant rejection with indium-111-labeled lymphocytes. Circulation 1995; 92(suppl 1): 1-577.

13. Frist W, Yasuda T, Segall G, Khaw BA, Strauss HW, Gold H, et al: Noninvasive detection of human cardiac transplant rejection with indium-111 monoclonal antimyosin Fab. Circulation 1987; 76(suppl V): V-81.

14. Carrio I, Bema L, Ballester M, Estorch M, Obrador D, Cladellas M, et al: Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1893-900.

15. Khaw B-A, Narula J: Antibody imaging in the evaluation of cardiovascular diseases. J Nucl Cardiol 1994; 1: 457-76.

16. Ballester M, Obrador D, Carrio I, Auge JM, Moya C, Pons-Lladó G, et al: Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation: Identification of risk groups for developing rejection during long-term follow-up and clinical implications. Circulation 1990; 82: 2100-8

17. Puig M, Ballester M, Matías-Guiu X, Bordes R, Carrió I, Holodgie FD, et al: Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocite necrosis and apoptosis. J Nucl Cardiol 2000; 7: 132-9.

18. Narula J, Kharbanda S, Khaw BA: Apoptosis and the heart. Chest 1997; 112: 1358-62.

19. Blankenberg F, Strauss HW, Narula J: In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia and failure. J Nucl Cardiol 1999; 6: 531-9.

20. Guertner C, Krause BJ, Klepzig H: Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination. Eur J Nucl Med 1995; 22: 443-452.

21. Estorch M, Camprecios M, Flotats A, Mari C, Berna L, Catafau AM, et al: Sympathetic reinnervation of cardiac allograft evaluated by 1231-MIBG imaging. J Nucl Med 1999; 40: 911-6.

22. DeMarco T, Dae MW, Yuen-Green MS: Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: Evidence for late reinnervation. J Am Coll Cardiol 1995; 25: 927-931.

23. Gill JS, Hunter GJ, Gane G, Camm AJ: Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine-123-labeled metalodobenzylguanidine scintigraphy. Am Heart J 1993; 126: 390-398.

24. Schwaiger M, Hutchins GD, Kaliff V: Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991; 87: 1681-90.

25. Krivokapich J, Stevenson LW, Kobashigawa J, Huang SC, Schelbert HR: Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. Circulation 1991; 18: 512-7.

26. Drake-Holland AJ, Cummins P, English TA, Wallwork J, Birch PJ: Metabolic changes in the autotransplanted bsboon heart. Transplantation 1984; 38: 454-9.

27. Leenen FHH, Davies RA, Fourney A: Role of cardiac b2-receptors in cardiac responses to exercise in cardiac transplant patients. Circulation 1995; 91: 685-90.

28. Bennett WM, Porter GA: Cyclosporine associated hypertension. Am J Med 1988; 85: 131-3.

29. Gao SZ, Alderman EL, Schroeder ES, Silverman JF, Hunt SA: Accelerated coronary vascular disease in the heart transplant patient: coronary angiographic findings. J Am Coll Cardiol 1990; 16: 586-95.

30. Hoff SJ, Stewart JR, Frist WH: Noninvasive detection of heart transplant rejection with positron emission scintigraphy. Ann Thorac Surg 1992; 53: 572-7.

31. Banner NR, Lloyd MH, Hamilton RD, Innes JA, Guz A, Yacoub M: Cardiopulmonary response to dynamic exercise after heart and combined heart-ling transplantation. Br Heart J 1989; 61: 215-23.

32. Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo L, Jones T, Maseri A, et al: Enhanced myocardial 18F-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol 1997; 30: 533-8.

33. Gao S, Schroeder J, Alderman E, Hunt S, Stinson E: Clinical and laboratory correlates on accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987; 76 Suppl V: V56-V61.

34. Gao S, Schroeder J, Hunt S, Stinson E: Retransplantation for severe vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334-40.

35. Hosenspud JD, Shipley GD, Wagner CR: Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant 1992; 11: 9-23.

36. O’neill BJ, Pflugfelder PW, Singh NH, Menkis AH, Mckenzie FN, Kostuk WJ: Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol 1989; 63: 1221-6.

37. Verhoeven P, Forrester AL, Ramahi T, Franco K, Mendes de León C, Amatruda J, et al: Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation. J Am Coll Cardiol 1996; 28: 183-9.

38. Ciliberto GR, Mangiavacchi M, Banfi F, Massa D, Danzi G, Cataldo G, et al: Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy. Eur Heart J 1993; 14: 226-9.